Mouse Models as Tools to Explore Cytidine-to-Uridine RNA Editing

Methods in Enzymology

Volumn 424, Issue , 2007, Pages 417-435

  Cho, Soo Jin ^a   Blanc, Valerie ^a   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; APOBEC 1 COMPLEMENTATION FACTOR; APOLIPOPROTEIN B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CYTIDINE; HOLOENZYME; INOSINE; REGULATOR PROTEIN; SODIUM METABISULFITE; UNCLASSIFIED DRUG; URIDINE; APOLIPOPROTEIN B MRNA EDITING ENZYME; CYTIDINE DEAMINASE; LIPID; MESSENGER RNA; THYROID HORMONE;

DEAMINATION; GENETIC REGULATION; GENETIC VARIABILITY; GENOME; KNOCKOUT MOUSE; LIPID METABOLISM; LIPID TRANSPORT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; RNA EDITING; TRANSGENIC MOUSE; ANIMAL; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CHEMISTRY; GENETIC PROCEDURES; GENETICS; MALE; METABOLISM; METHODOLOGY; RAT;

MURINAE; RODENTIA;

ANIMALS; APOLIPOPROTEINS B; BIOCHEMISTRY; CYTIDINE; CYTIDINE DEAMINASE; GENETIC TECHNIQUES; LIPIDS; MALE; MICE; MODELS, ANIMAL; RATS; RNA EDITING; RNA, MESSENGER; THYROID HORMONES; URIDINE;

EID: 34548587816     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)24019-4     Document Type: Chapter

References (71)

1. Anant S., Mukhopadhyay D., Sankaranand V., Kennedy S., Henderson J.O., and Davidson N.O. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing. Am. J. Physiol. Cell Physiol. 281 (2001) C1904-C1916
2. Baum C.L., Teng B.B., and Davidson N.O. Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. J. Biol. Chem. 265 (1990) 19263-19270
3. Blanc V., and Davidson N.O. C-to-U RNA editing: mechanisms leading to genetic diversity. J. Biol. Chem. 278 (2003) 1395-1398
4. Blanc V., Henderson J.O., Kennedy S., and Davidson N.O. Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity. J. Biol. Chem. 276 (2001) 46386-46393
5. Blanc V., Henderson J.O., Newberry E.P., Kennedy S., Luo J., and Davidson N.O. Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality. Mol. Cell. Biol. 25 (2005) 7260-7269
6. Blanc V., Kennedy S., and Davidson N.O. A novel nuclear localization signal in the auxiliary domain of apobec-1 complementation factor regulates nucleocytoplasmic import and shuttling. J. Biol. Chem. 278 (2003) 41198-41204
7. Bonen D.K., Nassir F., Hausman A.M., and Davidson N.O. Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro. J. Lipid Res. 39 (1998) 1629-1640
8. Boogaerts J.R., Malone-McNeal M., Archambault-Schexnayder J., and Davis R.A. Dietary carbohydrate induces lipogenesis and very-low-density lipoprotein synthesis. Am. J. Physiol. 246 (1984) E77-E83
9. Cappione A.J., French B.L., and Skuse G.R. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. Am. J. Hum. Genet. 60 (1997) 305-312
10. Chen S.H., Habib G., Yang C.Y., Gu Z.W., Lee B.R., Weng S.A., Silberman S.R., Cai S.J., Deslypere J.P., Rosseneu M., Gotto M., Li W.-H., and Chan L. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238 (1987) 363-366
11. Davidson N.O., Powell L.M., Wallis S.C., and Scott J. Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. J. Biol. Chem. 263 (1988) 13482-13485
12. Davidson N.O., and Shelness G.S. A polipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu. Rev. Nutr. 20 (2000) 169-193
13. Davis R.A., and Boogaerts J.R. Intrahepatic assembly of very low density lipoproteins. Effect of fatty acids on triacylglycerol and apolipoprotein synthesis. J. Biol. Chem. 257 (1982) 10908-10913
14. Davis R.A., Boogaerts J.R., Borchardt R.A., Malone-McNeal M., and Archambault-Schexnayder J. Intrahepatic assembly of very low density lipoproteins. Varied synthetic response of individual apolipoproteins to fasting. J. Biol. Chem. 260 (1985) 14137-14144
15. Elam M.B., Simkevich C.P., Solomon S.S., Wilcox H.G., and Heimberg M. Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo. Endocrinology 122 (1988) 1397-1402
16. Flamant F., Poguet A.L., Plateroti M., Chassande O., Gauthier K., Streichenberger N., Mansouri A., and Samarut J. Congenital hypothyroid Pax8(-/-) mutant mice can be rescued by inactivating the TRalpha gene. Mol. Endocrinol. 16 (2002) 24-32
17. Funahashi T., Giannoni F., DePaoli A.M., Skarosi S.F., and Davidson N.O. Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing. J. Lipid Res. 36 (1995) 414-428
18. Giannoni F., Bonen D.K., Funahashi T., Hadjiagapiou C., Burant C.F., and Davidson N.O. Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J. Biol. Chem. 269 (1994) 5932-5936
19. Greeve J., Altkemper I., Dieterich J.H., Greten H., and Windler E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J. Lipid Res. 34 (1993) 1367-1383
20. Gutierrez E.D., Grapperhaus K.J., and Rubin D.C. Ontogenic regulation of spatial differentiation in the crypt-villus axis of normal and isografted small intestine. Am. J. Physiol. 269 (1995) G500-G511
21. Henderson J.O., Blanc V., and Davidson N.O. Isolation, characterization and developmental regulation of the human apobec-1 complementation factor (ACF) gene. Biochim. Biophys. Acta 1522 (2001) 22-30
22. Hersberger M., Patarroyo-White S., Qian X., Arnold K.S., Rohrer L., Balestra M.E., and Innerarity T.L. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting. Biochem. J. 369 (2003) 255-262
23. Higuchi K., Kitagawa K., Kogishi K., and Takeda T. Developmental and age-related changes in apolipoprotein B mRNA editing in mice. J. Lipid Res. 33 (1992) 1753-1764
24. Hirano K., Young S.G., Farese Jr. R.V., Ng J., Sande E., Warburton C., Powell-Braxton L.M., and Davidson N.O. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271 (1996) 9887-9890
25. Horie Y., Fazio S., Westerlund J.R., Weisgraber K.H., and Rall Jr. S.C. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J. Biol. Chem. 267 (1992) 1962-1968
26. Inui Y., Giannoni F., Funahashi T., and Davidson N.O. REPR and complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux. J. Lipid Res. 35 (1994) 1477-1489
27. Kim E., and Young S.G. Genetically modified mice for the study of apolipoprotein B. J. Lipid Res. 39 (1998) 703-723
28. Lau P.P., Cahill D.J., Zhu H.J., and Chan L. Ethanol modulates apolipoprotein B mRNA editing in the rat. J. Lipid Res. 36 (1995) 2069-2078
29. Lau P.P., Xiong W.J., Zhu H.J., Chen S.H., and Chan L. Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. J. Biol. Chem. 266 (1991) 20550-20554
30. Lehmann D.M., Galloway C.A., Sowden M.P., and Smith H.C. Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor. Nucleic Acids Res. 34 (2006) 3299-3308
31. Leighton J.K., Joyner J., Zamarripa J., Deines M., and Davis R.A. Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: Evidence that the total amount of apoB secreted is regulated post-transcriptionally. J. Lipid Res. 31 (1990) 1663-1668
32. Lellek H., Kirsten R., Diehl I., Apostel F., Buck F., and Greeve J. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J. Biol. Chem. 275 (2000) 19848-19856
33. Liao W., Hong S.H., Chan B.H., Rudolph F.B., Clark S.C., and Chan L. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. Biochem. Biophys. Res. Commun. 260 (1999) 398-404
34. Liu C.Y., Broadhurst R., Marcovina S.M., and McCormick S.P. Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation. J. Lipid Res. 45 (2004) 63-70
35. Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., Munk C., Nymark-McMahon H., and Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114 (2003) 21-31
36. McCormick S.P., Linton M.F., Hobbs H.H., Taylor S., Curtiss L.K., and Young S.G. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein. J. Biol. Chem. 269 (1994) 24284-24289
37. McCormick S.P., Ng J.K., Cham C.M., Taylor S., Marcovina S.M., Segrest J.P., Hammer R.E., and Young S.G. Transgenic mice expressing human ApoB95 and ApoB97. Evidence that sequences within the carboxyl-terminal portion of human apoB100 are important for the assembly of lipoprotein. J. Biol. Chem. 272 (1997) 23616-23622
38. Mehta A., Kinter M.T., Sherman N.E., and Driscoll D.M. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell Biol. 20 (2000) 1846-1854
39. Mikl M.C., Watt I.N., Lu M., Reik W., Davies S.L., Neuberger M.S., and Rada C. Mice deficient in APOBEC2 and APOBEC3. Mol. Cell Biol. 25 (2005) 7270-7277
40. Morrison J.R., Paszty C., Stevens M.E., Hughes S.D., Forte T., Scott J., and Rubin E.M. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc. Natl. Acad. Sci. USA 93 (1996) 7154-7159
41. Mukhopadhyay D., Anant S., Lee R.M., Kennedy S., Viskochil D., and Davidson N.O. C→U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme. Am. J. Hum. Genet. 70 (2002) 38-50
42. Mukhopadhyay D., Plateroti M., Anant S., Nassir F., Samarut J., and Davidson N.O. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic acid editing in a murine model of congenital hypothyroidism. Endocrinology 144 (2003) 711-719
43. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
44. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., and Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274 (1999) 18470-18476
45. Nakamuta M., Chang B.H., Zsigmond E., Kobayashi K., Lei H., Ishida B.Y., Oka K., Li E., and Chan L. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J. Biol. Chem. 271 (1996) 25981-25988
46. Ness G.C., and Zhao Z. Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats. Arch. Biochem. Biophys. 315 (1994) 199-202
47. Okazaki I.M., Hiai H., Kakazu N., Yamada S., Muramatsu M., Kinoshita K., and Honjo T. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197 (2003) 1173-1181
48. Patterson A.P., Chen Z., Rubin D.C., Moucadel V., Iovanna J.L., Brewer Jr. H.B., and Eggerman T.L. Developmental regulation of apolipoprotein B mRNA editing is an autonomous function of small intestine involving homeobox gene Cdx1. J. Biol. Chem. 278 (2003) 7600-7666
49. Phung T.L., Sowden M.P., Sparks J.D., Sparks C.E., and Smith H.C. Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat. Metabolism 45 (1996) 1056-1058
50. Plateroti M., Chassande O., Fraichard A., Gauthier K., Freund J.N., Samarut J., and Kedinger M. Involvement of T3R alpha- and beta-receptor subtypes in mediation of T3 functions during postnatal murine intestinal development. Gastroenterology 116 (1999) 1367-1378
51. Powell L.M., Wallis S.C., Pease R.J., Edwards Y.H., Knott T.J., and Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50 (1987) 831-840
52. Qian X., Balestra M.E., Yamanaka S., Boren J., Lee I., and Innerarity T.L. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1013-1020
53. Seishima M., Bisgaier C.L., Davies S.L., and Glickman R.M. Regulation of hepatic apolipoprotein synthesis in the 17 alpha-ethinyl estradiol-treated rat. J. Lipid Res. 32 (1991) 941-951
54. Sharp R.J., Perugini M.A., Marcovina S.M., and McCormick S.P. Structural features of apolipoprotein B synthetic peptides that inhibit lipoprotein(a) assembly. J. Lipid Res. 45 (2004) 2227-2234
55. Sjoberg A., Oscarsson J., Bostrom K., Innerarity T.L., Eden S., and Olofsson S.O. Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. Endocrinology 130 (1992) 3356-3364
56. Sowden M.P., Ballatori N., Jensen K.L., Reed L.H., and Smith H.C. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: Identification of intracellular domains containing active and inactive editing factors. J. Cell Sci. 115 (2002) 1027-1039
57. Srivastava R.A. Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA. Biochem. Biophys. Res. Commun. 212 (1995) 381-387
58. Teng B., Black D.D., and Davidson N.O. Apolipoprotein B messenger RNA editing is developmentally regulated in pig small intestine: nucleotide comparison of apolipoprotein B editing regions in five species. Biochem. Biophys. Res. Commun. 173 (1990) 74-80
59. Teng B., Blumenthal S., Forte T., Navaratnam N., Scott J., Gotto Jr. A.M., and Chan L. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J. Biol. Chem. 269 (1994) 29395-29404
60. Teng B., Burant C.F., and Davidson N.O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260 (1993) 1816-1819
61. Teng B., Verp M., Salomon J., and Davidson N.O. Apolipoprotein B messenger RNA editing is developmentally regulated and widely expressed in human tissues. J. Biol. Chem. 265 (1990) 20616-20620
62. Thorngate F.E., Raghow R., Wilcox H.G., Werner C.S., Heimberg M., and Elam M.B. Insulin promotes the biosynthesis and secretion of apolipoprotein B-48 by altering apolipoprotein B mRNA editing. Proc. Natl. Acad. Sci. USA 91 (1994) 5392-5396
63. Veniant M.M., Pierotti V., Newland D., Cham C.M., Sanan D.A., Walzem R.L., and Young S.G. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. J. Clin. Invest. 100 (1997) 180-188
64. von Wronski M.A., Hirano K.I., Cagen L.M., Wilcox H.G., Raghow R., Thorngate F.E., Heimberg M., Davidson N.O., and Elam M.B. Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes. Metabolism 47 (1998) 869-873
65. Wu J.H., Semenkovich C.F., Chen S.H., Li W.H., and Chan L. Apolipoprotein B mRNA editing. Validation of a sensitive assay and developmental biology of RNA editing in the rat. J. Biol. Chem. 265 (1990) 12312-12316
66. Xie Y., Nassir F., Luo J., Buhman K., and Davidson N.O. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G735-G746
67. Yamanaka S., Balestra M.E., Ferrell L.D., Fan J., Arnold K.S., Taylor S., Taylor J.M., and Innerarity T.L. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA 92 (1995) 8483-8487
68. Yamanaka S., Poksay K.S., Arnold K.S., and Innerarity T.L. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev. 11 (1997) 321-333
69. Yamanaka S., Poksay K.S., Driscoll D.M., and Innerarity T.L. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J. Biol. Chem. 271 (1996) 11506-11510
70. Yamane M., Jiao S., Kihara S., Shimomura I., Yanagi K., Tokunaga K., Kawata S., Odaka H., Ikeda H., Yamashita S., et al. Increased proportion of plasma apoB-48 to apoB-100 in non-insulin-dependent diabetic rats: Contribution of enhanced apoB mRNA editing in the liver. J. Lipid Res. 36 (1995) 1676-1685
71. Yao Z.M., Blackhart B.D., Johnson D.F., Taylor S.M., Haubold K.W., and McCarthy B.J. Elimination of apolipoprotein B48 formation in rat hepatoma cell lines transfected with mutant human apolipoprotein B cDNA constructs. J. Biol. Chem. 267 (1992) 1175-1182